Calando Pharmaceuticals Inc - CA Los Angeles, Pasadena 91101

Calando Pharmaceuticals Inc entered the industry of in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 3254120, which describes it as a . For further clarification, the SIC classifies this business under the code 2834 and described it as a . The business provides service to the B2B market.

To acquire more information, please contact James Hamilton, Chief Executive Officer by calling (626) 304-3400 during business hours. You can also write to the business’ Single Location at 225 South Lake Avenue Floor 3, Pasadena, California CA 91101. You can also visit the company’s website at calandopharma.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Calando Pharmaceuticals Inc
Representative: James Hamilton, Chief Executive Officer
Place of Business: 225 South Lake Avenue Floor 3, Pasadena, CA 91101
Contact Number: (626) 304-3400
Website: calandopharma.com
Type of Service:
SIC Number: 2834
NAICS Number: 3254120
Locality: Single Location
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Calando Pharmaceuticals Inc is a company operating from Los Angeles, California providing professional and relevant B2B variables. It was founded in 0 and registered with the SIC code 2834 as , and with the NAICS code 3254120 as .

With a current employee count of 1 to 4, Calando Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative James Hamilton, Chief Executive Officer at (626) 304-3400 for related queries, or to locate its Single Location using the coordinates 34.142079,-118.132399.

The Single Location can also be found at the street address 225 South Lake Avenue Floor 3 in Pasadena, California 91101 and can be engaged online through the company website at calandopharma.com, the company Twitter , and Facebook page .